Literature DB >> 3324599

Randomized comparison of imipenem/cilastatin and ceftazidime in the empiric therapy of severe abdominal infections. A multicenter study.

B Broze, J De Mees, R Droissart, V P Nolens, J P Staudt, M E Verstraeten, P A de Lame.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3324599     DOI： 10.1080/22953337.1987.11719261

Source DB:  PubMed          Journal:  Acta Clin Belg        ISSN： 1784-3286            Impact factor:   1.264


× No keyword cloud information.
  3 in total

Review 1.  Imipenem/cilastatin: a pharmacoeconomic appraisal of its use in intra-abdominal infections.

Authors:  P Benfield; P Chrisp
Journal:  Pharmacoeconomics       Date:  1992-06       Impact factor: 4.981

2.  Randomized multicenter clinical trial with imipenem/cilastatin versus cefotaxime/gentamicin in the treatment of patients with non-life-threatening infections. German and Austrian Imipenem/Cilastatin Study Group.

Authors: 
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-08       Impact factor: 3.267

3.  Carbapenems vs β-Lactam Monotherapy or Combination Therapy for the Treatment of Complicated Intra-abdominal Infections: Systematic Review and Meta-analysis of Randomized Controlled Trials.

Authors:  Yan Li; Lingyuan Chen; Junsong Jiang; Xianshu Li; Tianguo Huang; Xueyan Liang
Journal:  Open Forum Infect Dis       Date:  2019-09-09       Impact factor: 3.835
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.